Circadian Rhythm Deregulation in Patients With CAPS
NCT06544018 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2026-02-27
Summary
Circadian rhythms are characterized by the physiology's adaptation to the alternation of day and night, enabling to adapt to the environment. These rhythms are generated by a molecular clock within each cell. At the molecular level, the circadian clock is based on a complex system of cell-autonomous transcription loops. These exert positive and negative feedback on themselves, generating cyclic transcriptional activity.
* In the main loop, the BMAL1 transcription factor links with CLOCK or NPAS2 ( (Neuronal PAS Domain Protein 2) to activate transcription of per1,2 and 3 and cryptochrome (cry1 and cry2), which in turn repress BMAL1/CLOCK1 transcriptional activity.. The BMAL1/CLOCK complex also activates transcription of numerous target genes (per and cry, Rev-erb, etc.)..
* other secondary loops refine the function of the first.
Recent studies suggest that many aspects of innate immunity are controlled by circadian rhythm through inhibition of NLRP3 inflammasome activation. Nevertheless, the regulation of the NLRP3 inflammasome by the circadian clock has yet to be elucidated. Inflammasomes are molecular platforms that control caspase-1 activation and consequently the maturation of precursors of (interleukine) IL-1β, pro-IL-18, a pro-inflammatory cytokine. Since its discovery, its functions have been widely characterized as part of the innate immune response as a sensor of pathogens and danger signals (extracellular ATP (Adenosine triphosphate), atmospheric pollutants). NLRP3 (nucleotide-binding domain LRR (leucin-rich repeat ) and pyrin-containing receptor 3) has been described for its genetic association with dominant monogenic hereditary syndromes characterized by recurrent systemic inflammatory episodes in the absence of any infection or autoimmune disease, known as CAPS (cryopyrin-associated periodic syndrome) or cryopyrinopathies which is a continuum of diseases ranging from a moderate to the most severe form of the syndrome: familial cold urticaria syndrome, Muckle-Wells syndrome (MWS), and CINCA/NOMID syndrome.
Interestingly, patients with Muckle-Wells syndrome show a circadian pattern of symptoms, with a recurrent, predominantly vesperal fever peak lasting a few hours, and extreme fatigue on a daily basis. However, a molecular link between the circadian clock and CAPS pathology remains to be determined.
The aim of this protocol is to identify circadian rhythm dysregulation in patients with CAPS confirmed by genetic analysis of NLRP3, to demonstrate a link between circadian clock and CAPS syndrome, and to identify circadian clock regulatory pathways.
Conditions
- Cryopyrin Associated Periodic Syndrome
- Familial Cold Urticaria
- Muckle-Wells Syndrome
- CINCA Syndrome
Interventions
- GENETIC
-
Genetic analysis of NLRP3
Blood test for genetic analysis of NLRP3
- DEVICE
-
Circadian rhythm measurement
Wear a Withings Pulse HR (heart rate) actigraphic watch 24 hours a day for 1 month to define circadian rhythm
- BIOLOGICAL
-
Saliva sampling
Saliva sampling for salivary melatonin determination
- OTHER
-
Questionnaire
Questionnaire to determine chronotype
- OTHER
-
AIDAI score
Disease activity score using AIDAI score (only for patients in the CAPS group) AIDAI : AUTO-INFLAMMATORY DISEASE ACTIVITY INDEX
- BIOLOGICAL
-
Blood sampling
1. Inflammatory cytokines measurement : IL1-beta (Interleukin-1) and IL-18. 2. Molecular characterization of circadian clock signaling pathways
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-02-25
- Primary Completion
- 2029-02-25
- Completion
- 2029-02-25
Countries
- France
Study Locations
More Related Trials
-
Subclassification of the Syndrome of Inappropriate ADH Secretion
NCT01341665 ·Status: COMPLETED
-
The Kidneys Ability to Concentrate and Dilute Urine in Patients With Autosomal Dominant Polycystic Kidney Disease
NCT04363554 ·Status: COMPLETED ·Phase: NA
-
Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus
NCT00004363 ·Status: COMPLETED
-
Hyperekplexia : Adaptative Skills and Neurodevelopmental Trajectory
NCT05652101 ·Status: RECRUITING
-
Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome
NCT02368379 ·Status: COMPLETED ·Phase: NA
-
Impact of Dysregulation of Core Body Temperature on Sleep in Patients With Hypohidrotic Ectodermal Dysplasia
NCT05378932 ·Status: COMPLETED ·Phase: NA
-
Neuroendocrine Dysfunction in Critically Ill Pediatric Patients
NCT00207896 ·Status: COMPLETED
-
Development of Health-related Quality of Life Instrument for Patients With Cystinosis
NCT05959668 ·Status: RECRUITING
-
Evaluation of A Clinical Diagnostic Test for CRDS
NCT06188689 ·Status: RECRUITING ·Phase: NA
-
Salt Wasting, Hydro-sodium Balance and Fludrocortisone Requirement in Congenital Adrenal Hyperplasia
NCT03550261 ·Status: COMPLETED
-
Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia
NCT00004669 ·Status: COMPLETED ·Phase: PHASE2
-
Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine
NCT00298753 ·Status: WITHDRAWN ·Phase: PHASE4
-
The Role of the Glymphatic System Avaluated Thourgh mr Imaging in the Diagnosis and Management of NPH
NCT06857136 ·Status: COMPLETED
-
Study of Cushing's Syndrome Not Related to ACTH Production
NCT00006278 ·Status: COMPLETED
-
Study of Novel Types of Familial Diabetes Insipidus
NCT00004364 ·Status: UNKNOWN
-
Normal Pressure Hydrocephalus Biomarkers Investigation
NCT05562596 ·Status: UNKNOWN
-
Parathyroid Hormone (PTH) Homeostasis in Bartter Syndrome
NCT01021280 ·Status: UNKNOWN
-
Water as Therapy in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT00759369 ·Status: COMPLETED ·Phase: NA
-
Maturational Changes in Cardiac Structures -- Blood Pressure Relationship -- SCOR in Hypertension
NCT00005469 ·Status: COMPLETED
-
International CRDS Registry
NCT06508164 ·Status: RECRUITING
-
At Home Ammonia Monitoring of Inborn Errors of Ammonia Metabolism
NCT06953505 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water Homeostasis
NCT01465672 ·Status: COMPLETED
-
Assessment of CAI in Adults With PWS.
NCT04700644 ·Status: COMPLETED
-
Desmopressin Melt: Impact on Sleep and Daytime Functioning
NCT01645475 ·Status: COMPLETED ·Phase: PHASE4
-
Biomarkers of CYP2D6 and CYP3A4 Variability in Pediatrics
NCT01118858 ·Status: COMPLETED